Changes in CLL Platelet Granularity and Membrane Expression of αIIbβ3 and GPVI, but not FcγRIIA, Are Differentially Dependent on Ibrutinib Treatment. The gene discussed is GP6; the disease is B-cell chronic lymphocytic leukemia.